Clinical Trials Logo

Altitude Sickness clinical trials

View clinical trials related to Altitude Sickness.

Filter by:

NCT ID: NCT05734716 Completed - Clinical trials for Acute Mountain Sickness

Colorado-Oregon Altitude Study

COAST
Start date: February 17, 2021
Phase: Phase 4
Study type: Interventional

Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.

NCT ID: NCT05733338 Recruiting - Clinical trials for Acute Mountain Sickness

The Effects of Intermittent Hypoxia on Acute Hypoxic Injury

Start date: March 1, 2023
Phase: N/A
Study type: Interventional

This study intends to further reveal the effectiveness of intermittent hypoxia in preventing acute hypoxic injury.

NCT ID: NCT05603689 Completed - Physical Activity Clinical Trials

Effect of Isocaloric Ketogenic Diet on Physical Performance at High Altitude

ICKD
Start date: September 1, 2020
Phase: N/A
Study type: Interventional

A ketogenic diet (KD) reduces daily carbohydrates (CHOs) ingestion by replacing most calories with fat. KD is of increasing interest among athletes because it may increase their maximal oxygen uptake (VO2max), the principal performance limitation at high altitudes. The investigators examined the tolerance of a 4-week isocaloric KD (ICKD) under simulated hypoxia and the possibility of evaluating ICKD performance benefits with a maximal graded exercise bike test under hypoxia and collected data on the effect of the diet on performance markers and arterial blood gases.

NCT ID: NCT05584813 Completed - Hypoxia, Altitude Clinical Trials

Colour Vision Impairment During Acute Hypobaric Hypoxia

Start date: July 1, 2019
Phase: N/A
Study type: Interventional

This study analyses the impairment of colour vision during hypobaric hypoxia in volunteers of different groups.

NCT ID: NCT05575180 Completed - Clinical trials for High Altitude Effects

Effect of Acetazolamide and Methazolamide on Hypoxic Exercise Performance

Start date: August 11, 2023
Phase: Phase 4
Study type: Interventional

A single-centered randomized doubled blinded placebo-controlled cross-over trial comparing two the effect of two carbonic anhydrase inhibitors on exercise performance in acute hypoxia. Participants will be young (under 40 years of age), healthy males and females who are regularly physically active.

NCT ID: NCT05517044 Active, not recruiting - Clinical trials for Perfusion; Complications

The Pre-acclimatization Augmented Extreme Altitude Expedition

PRAGMAX
Start date: August 4, 2022
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the effect of pre-acclimatization in a nitrogen tent at home, ventilated with a slightly increased nitrogen percentage, in preparation for an expedition at extreme altitude. Specifically, the current study aims to gather knowledge, whether pre-acclimatization, first, leads to improved capillary function during an expedition to extreme altitude, and second, affects incidence of altitude sickness and the likelihood of reaching the expedition destination without oxygen supplementation. The project will be carried out in two phases corresponding to two randomized controlled trials in healthy volunteers, who are participating in an expedition at extreme altitudes with or without pre-acclimatization.

NCT ID: NCT05500014 Active, not recruiting - Clinical trials for Iron Deficiency Anemia

Effect of Altitude on Iron Absorption in Iron Depleted Women

PotatoAlt
Start date: August 20, 2022
Phase: N/A
Study type: Interventional

One of the most common nutritional deficiencies worldwide is iron deficiency. Iron deficiency is considered the main cause of anaemia in developing countries, including those in South America. The most recent surveys report that the prevalence of anaemia is as high as, 40 and 25% in Peru. Populations living at higher altitudes may have higher iron requirements, as body iron is naturally increased in long-term high-altitude residents to compensate for the lower oxygen in the air at high altitudes. However, the effects of chronic exposure to high altitude on iron status, body iron compartments and dietary iron requirements are incompletely understood. The primary objective of the proposed research is to determine iron bioavailability of iron from biofortified potatoes at different altitudes in populations of Andean descent. Human trials will be undertaken with volunteers in the Huancavelica region of Peru (elevation: 3676 meters) as well as in Lima (elevation close to sea level). The aim is to assess the effect of altitude on the absorption from a promising iron biofortified potato cultivar. These trials require incorporation of iron stable isotopes into the meals of the bio fortified potato and the analysis of the isotopes in subsequent blood (red blood cells) samples. Stable iron istotopes are considered the golden standard to assess human iron absorption and can be safely used as tracer substances in humans. The objective of the study is to compare, in volunteer females of childbearing age, the bioavailability of iron from bio-fortified potatoes in two locations of different altitudes and quantify the effect of altitude on iron bioavailability from a potato meal consumed over 5 consecutive days.

NCT ID: NCT05474287 Recruiting - Hypoxia Clinical Trials

SJOV vs. HFNO for Hypoxia During Procedural Sedation at High Altitudes

Start date: October 14, 2022
Phase: N/A
Study type: Interventional

This study aims to compare the effect of the use of supraglottic jet oxygenation and ventilation (SJOV) with high-flow nasal oxygen therapy (HFNO) on reducing the rate of hypoxia during gastrointestinal endoscopic procedures in deeply sedated patients at high altitudes.

NCT ID: NCT05468515 Completed - Neonatal Disease Clinical Trials

Reference Interval for SPO2 in Neonates at High Altitudes During First 2 Hours and Umbilical Artery Blood Gas

Start date: March 15, 2022
Phase:
Study type: Observational

Pulse oximetry offers real time and non-invasive estimation of arterial oxygen saturation in a cost-effective way, and has become a critical tool in guiding the usage of supplemental oxygen in sick newborns. During postnatal transition, pulmonary pressure decreases upon the activation of the lungs, and the ductus arteriosus constricts and closes upon the increase of partial oxygen pressure, which is negatively correlated with altitude. As a result, postnatal transition may be different at high altitudes. Umbilical cord blood gas analysis is now recommended in all high-risk deliveries because of its' value in providing information about preceding fetal hypoxic stress. But there are only limited studies about the SpO2 measurements during the first few hours after birth and umbilical blood gas analysis at high altitudes, especially at altitudes above 2500m. The primary outcome of the study is to determine the reference intervals for preductal oxygen saturation during first 2 hours of life stratified by different gestational age. The secondary outcomes is to establish the pH and lactate cutoff value of umbilical arterial blood gas at different altitude level.

NCT ID: NCT05411185 Completed - Cognition Clinical Trials

The Study on Effects of Acute Exposure to High Altitude Hypoxia on Cognitive Function in Lowlanders

Start date: January 1, 2022
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to investigate the impact of rapid elevation to 3,800 meters on the cognitive function of low-altitude residents through a plateau field and plain control study, and explore the objective indicators related to the impaired cognitive function.